2. Academic Validation
  3. Selective DYRK1A Inhibitor for the Treatment of Neurodegenerative Diseases: Alzheimer, Parkinson, Huntington, and Down Syndrome

Selective DYRK1A Inhibitor for the Treatment of Neurodegenerative Diseases: Alzheimer, Parkinson, Huntington, and Down Syndrome

  • ACS Med Chem Lett. 2020 Jul 9;11(10):1795-1796. doi: 10.1021/acsmedchemlett.0c00346.
Robert B Kargbo 1
Affiliations

Affiliation

  • 1 Usona Institute, 277 Granada Drive, San Luis Obispo, California 93401-7337, United States.
PMID: 33062155 DOI: 10.1021/acsmedchemlett.0c00346
Figures